Diagnostic value of p53 immunohistochemistry in Barrett's esophagus: An endoscopic study
- 1 January 1998
- Vol. 30 (2) , 136-140
- https://doi.org/10.1080/00313029800169076
Abstract
Summary The aim of this study was to establish the diagnostic utility of p53 immunohistochemistry in Barrett's esophagus. Three pathologists reviewed endoscopic biopsy specimens and one surgical specimen derived from 102 subjects in a prospective follow-up series. Dysplasia was graded as negative, indefinite, low grade and high grade, p53 staining was assessed as negative, weak or patchy and strong. Kappa coefficients for interobserver agreement for the three combinations of observer pairs were moderate to substantial (0.48, 0.55 and 0.68)for dysplasia and substantial to near perfect (0.77, 0.82 and 0.89) for p53 immunostaining. In the consensus grading achieved for dysplasia, strong p53 staining was recorded in 0/79 samples that were negative or indefinite for dysplasia, 5/15 (33%) examples of low grade dysplasia and 7/8 (87%) examples of high grade dysplasia. Non-dysplastic p53 positive glands were seen in specimens from two subjects harbouring dysplasia or cancer elsewhere. Two p53 positive specimens were, upon review and discussion, re-assigned from low- to high-grade dysplasia. It is concluded that p53 immunohistochemistry facilitates the interpretation of Barrett's epithelium but need only be employed to confirm a suspected diagnosis of dysplasia and assist with the distinction between low- and high-grade dysplasia.Keywords
This publication has 29 references indexed in Scilit:
- Mutations of p53 in barrett's esophagus and barrett's cancer: A prospective study of ninety-eight casesThe Journal of Thoracic and Cardiovascular Surgery, 1996
- Potential application of p53 as an intermediate biomarker in Barrett's esophagusThe Annals of Thoracic Surgery, 1994
- Overexpression of p53 protein in Barrett's syndrome with malignant transformation.Journal of Clinical Pathology, 1993
- Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus.Gut, 1991
- The p53 tumour suppressor geneNature, 1991
- Surgical Therapy in Barrettʼs EsophagusAnnals of Surgery, 1990
- The Incidence of Adenocarcinoma in Columnar-Lined (Barrett's) EsophagusNew England Journal of Medicine, 1985
- Barrettʼs EsophagusAnnals of Surgery, 1983
- Weighted kappa: Nominal scale agreement provision for scaled disagreement or partial credit.Psychological Bulletin, 1968
- A Coefficient of Agreement for Nominal ScalesEducational and Psychological Measurement, 1960